Based on news reporting.
AbbVie Inc.'s subsidiary, Allergan, has laid off over 200 employees following a failed marketing campaign. The decision comes as part of a restructuring effort to realign the company's focus and resources. The layoffs are indicative of the challenges faced by Allergan in effectively promoting its products. While specific locations and departments affected were not disclosed, the cuts reflect a significant adjustment in workforce strategy. This move is part of AbbVie's broader efforts to streamline operations and enhance efficiency in a competitive market.
AbbVie Inc. cut 200 jobs as of October 1, 2023.
That is roughly 0.4% of the 50,000 people AbbVie Inc. employs.
LayoffTalk has tracked 10 layoff events at AbbVie Inc. since October 2023, affecting a combined 794 employees.
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Share your story anonymously — it helps others reading this feel less alone.
Share your story →Recent tracked events at this company.